Medical Treatment of Non-alcoholic Steatohepatitis
There is no proven medical treatment of non-alcoholic steatohepatitis (NASH). Most prior therapeutic trials have had methodologic limitations. Insulin sensitizers are the more promising therapeutic candidates among categories that include antioxidants, lipid-lowering agents, and antiobesity drugs. The future will see the evaluation of novel agents and a comprehensive treatment strategy that addresses the risk factors for the metabolic syndrome. This article reviews the current status of medical management options for NASH.
aDivision of Gastroenterology, Department of Medicine, 513 Parnassus Avenue, Room S-357, University of California, San Francisco, San Francisco, CA 94143-0538, USA
bDivision of Gastroenterology, Department of Medicine, University of Gaziantep, 27310 Gaziantep, Turkey
Corresponding author. Division of Gastroenterology, Department of Medicine, 513 Parnassus Avenue, Room S-357, University of California, San Francisco, San Francisco, CA 94143-0538.
ABSTRACT